The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Mental health outcomes associated with the use of amphetamines: A systematic review and meta-analysis
Open accessAbstract
BACKGROUND: The use of amphetamines is a global public health concern. We summarise global data on use of amphetamines and mental health outcomes. METHODS: A systematic review and meta-analysis (CRD 42017081893). We searched Medline, EMBASE, PsycInfo for methamphetamine or amphetamine combined with psychosis, violence, suicidality, depression or anxiety. Included studies were human empirical cross-sectional surveys, case-control studies, cohort studies and randomised controlled trials that assessed the association between methamphetamine and one of the mental health outcomes. Random effects meta-analysis was used to pool results for any use of amphetamines and amphetamine use disorders. FINDINGS: 149 studies were eligible and 59 were included in meta-analyses. There was significant heterogeneity in effects. Evidence came mostly from cross-sectional studies. Any use of amphetamines was associated with higher odds of psychosis (odds ratio [OR] = 2.0, 95%CI 1.3-3.3), violence (OR = 2.2, 95%CI 1.2-4.1; adjusted OR [AOR] = 1.4, 95%CI 0.8-2.4), suicidality OR = 4.4, 95%CI 2.4-8.2; AOR = 1.7, 95%CI 1.0-2.9) and depression (OR = 1.6, 95%CI 1.1-2.2; AOR = 1.3, 95%CI 1.2-1.4). Having an amphetamine use disorder was associated with higher odds of psychosis (OR = 3.0, 95%CI 1.9-4.8; AOR = 2.4, 95%CI 1.6-3.5), violence (OR = 6.2, 95%CI 3.1-12.3), and suicidality (OR = 2.3, 95%CI 1.8-2.9; AOR = 1.5, 95%CI 1.3-1.8). INTERPRETATION: Methamphetamine use is an important risk factor for poor mental health. High quality population-level studies are needed to more accurately quantify this risk. Clinical responses to methamphetamine use need to address mental health harms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709 · cited 2×
“[25] Sterne JAC , Sutton AJ , Ioannidis JPA , et al.”
BackgroundMetan: fixed- and random-effects meta-analysis
Harris, R. J., Deeks, J. J., Altman, D. G., Bradburn, M. J., Harbord, R. M., & Sterne, J. A. C. (2008) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0800800102 · Cited by 1,027
The nature, time course and severity of methamphetamine withdrawal
McGregor, C., Srisurapanont, M., Jittiwutikarn, J., Laobhripatr, S., Wongtan, T., & White, J. M. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01160.x · Cited by 458
McKetin, R., Lubman, D. I., Baker, A. L., Dawe, S., & Ali, R. L. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.283 · Cited by 221 · cited 1×
“…of psychosis McKetin (2010) [28] Australia 2008–9 Dance venue attendees in Sydney CS 88 157 (75) 62 20 ̂ Any psychotic symptom (Psychosis Screen) McKetin (2013) [29] Australia 2006–7 Prospective cohort of people recruited on entry to community-based drug treatment programs for…”
BackgroundSelf-citationCrystalline methamphetamine use and methamphetamine‐related harms in Australia
Degenhardt, L., Sara, G., McKetin, R., Roxburgh, A., Dobbins, T., Farrell, M., Burns, L., & Hall, W. D. (2017) · Drug and Alcohol Review · doi:10.1111/dar.12426 · Cited by 159
Self-citationMethamphetamine use and schizophrenia: A population-based cohort study in California
Callaghan, R. C., Cunningham, J. K., Allebeck, P., Arenovich, T., Sajeev, G., Remington, G., Boileau, I., & Kish, S. J. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10070937 · Cited by 150 · cited 5×
“no amphetamine use disorder) Callaghan (2012) [40] United States 1990–2000 Patients dependent on amphetamines admitted to Californian hospitals as identified through the California inpatient hospital admissions database CO 91 10,815,900 (36,162) 35 22 Schizophrenia diagnosis”
BackgroundInfluentialSuicidal ideation and attempts among sexual minority youths receiving social services
Walls, N. E., Freedenthal, S., & Wisneski, H. (2008) · Social Work · doi:10.1093/sw/53.1.21 · Cited by 107
'Third wave' cognitive and behavioural therapies versus treatment as usual for depression
Churchill, R., Moore, T. H., Furukawa, T. A., Caldwell, D. M., Davies, P., Jones, H., Shinohara, K., Imai, H., Lewis, G., & Hunot, V. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008705.pub2 · Cited by 82 · cited 1×
“[93] Churchill R , Moore TH , Furukawa TA , et al.”
Background
Cited by
Li, Y., Wang, A., Wu, Y., Han, N., & Huang, H. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.669119 · Cited by 421
Responding to global stimulant use: challenges and opportunities
Farrell, M., Martin, N. K., Stockings, E., Bórquez, A., Cepeda, J. A., Degenhardt, L., Ali, R., Tran, L. T., Rehm, J., Torrens, M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32230-5 · Cited by 310
Self-citationWhiting, D., Lichtenstein, P., & Fazel, S. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30262-5 · Cited by 311
A systematic review of substance use and substance use disorder research in Kenya
Jaguga, F., Kiburi, S. K., Temet, E., Barasa, J., Karanja, S., Kinyua, L., & Kwobah, E. K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269340 · Cited by 26
Elison-Davies, S., Newsome, J., Jones, A., Davies, G., & Ward, J. (2022) · Health & Justice · doi:10.1186/s40352-022-00190-w · Cited by 13
Metadata
- Authors
- McKetin, R., Leung, J., Stockings, E., Huo, Y., Foulds, J., Lappin, J. M., Cumming, C., Arunogiri, S., Young, J. T., Sara, G., Farrell, M., & Degenhardt, L.
- Venue
- EClinicalMedicine
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 16
- Pages
- 81-97
- ISSN
- 2589-5370 (ISSN-L)
- OpenAlex
- W2980419158
- Cited by
- 191
- References
- 8
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mental health outcomes associated with the use of amphetamines: A systematic review and meta-analysis. https://app.cochat.ai/papers/10.1016/j.eclinm.2019.09.014
- The paper
- McKetin, R., Leung, J., Stockings, E., Huo, Y., Foulds, J., Lappin, J. M., Cumming, C., Arunogiri, S., Young, J. T., Sara, G., Farrell, M., & Degenhardt, L. (2019). Mental health outcomes associated with the use of amphetamines: A systematic review and meta-analysis. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2019.09.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.